ClinicalTrials.gg
CompletedNCT04081454Updated May 1, 2024

Comfortability Workshop

An observational study in Chronic Pain, sponsored by Washington University School of Medicine. Completed at 1 site in United States. Open to participants aged 11 Years to 17 Years. Per ClinicalTrials.gov, last updated 2024-05-01.

Sponsored by Washington University School of Medicine · Observational

Study type
Observational
Model
Family-based
Time perspective
Prospective
Enrollment
13
Ages
11 Years to 17 Years
Sex
All
01

Study summary

The Comfort Ability is a fun and interactive one-day (6 hour) program to help children and their parents or caregivers learn how to better manage chronic pain. The program introduces cognitive-behavioral and bio-behavioral pain management strategies to emphasize the mind-body connection and offers non-invasive and non-pharmaceutical strategies for improved pain management. Youth ages 11-18 with chronic or recurrent pain are eligible to sign up for Comfort Ability.

Read the detailed description

This 1-day, manualized clinical intervention includes a parent group and an adolescent group that run simultaneously, but separately. This program will be offered 4 times per calendar year. The program is 6-hours long and was run at an urban, Midwest children's hospital on a weekend day to maximize accessibility for families. Each group will include between 8 and 12 adolescents (ages 11-17 years) and 15-21 parents. The groups will be staffed by two PhD-level psychologists (one for the parent and one for the adolescent group), a psychology postdoctoral fellow, and nurse practitioner, one or two trained study assistants (e.g., psychology interns, nurse coordinator) who provide support, but not intervention content.

The adolescent program includes motivational interviewing, psychoeducation, and structured activities that emphasize the link between pain, negative cognitions (i.e., catastrophizing), avoidance behaviors, and mood. About one third of the day is devoted to in vivo practice of relaxation-based skills including diaphragmatic breathing, guided imagery, pain-reduction visualization, and biofeedback. Additionally, adolescents participate in several hands-on activities designed to enhance mind-body regulation including mindfulness practice (eating mindfully), art therapy, and aromatherapy. Adolescents complete interactive workbooks throughout the program; at the end of the day, each adolescent works one-on-one with staff to create a written and personalized pain management plan emphasizing the adaptive coping strategies each adolescent preferred during the day. Adolescents were additionally provided with a pain management tool kit inclusive of recorded relaxation exercises, a biofeedback card, and other small tools to enhance their pain management regimen.

The parent program includes psychoeducation regarding pain in the context of adolescent development, didactic and vignette-based practice of an adaptive parent communication response style (i.e., reflective listening), and concrete tools for setting up behavior plans to scaffold an adolescent's return to function for school, sleep, daily activities, and exercise. All parents are provided with a take-home workbook inclusive of neuroscience and psychoeducational materials as well as a list of resources to further solidify the information they learned.

In addition there will be peer support for parents and adolescents in this program. During the 1 day intervention families and youth will be encouraged to share discussions regarding their health journeys. A guest speaker will be invited to both groups sharing their experiences and journey of utilizing psychologically based interventions to assist with reducing pain and stress and associated disability. These speakers have not received training for this portion.

02

Conditions studied

  • Chronic Pain

Browse trials for

03

In context

Chronic Pain

2,999 studies on the registry are indexed under Chronic Pain; 706 are open to participants now.

This study's enrollment of 13 is below the median of 128 across 706 observational studies indexed under Chronic Pain.

Browse Chronic Pain studies →

Lead sponsor

Washington University School of Medicine is the lead sponsor of 1,795 studies on the registry; 270 are open to participants now.

Of its 330 completed or terminated interventional studies of FDA-regulated products, 216 (65%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
11 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Children aged 11 - 17 with chronic pain and their parents or caregivers

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. 11 years to 17 years
  2. Ability to provide informed consent

Exclusion criteria

Exclusion Criteria:

  1. Cognitive Delay that may impact completion of questionnaires and involvement of youth group at workshop.
  2. Families without access to internet to complete 1 week, 1 month and 3 month follow up questionnaires.
05

Study design

Observational model
Family-based
Time perspective
Prospective
Enrollment
13 participants (actual)
Patient registry
No

Groups and cohorts

  • Children with chronic pain

    Behavioral: Workshop · Behavioral: Education

  • Caregivers of children with chronic pain

    Behavioral: Workshop · Behavioral: Education

Interventions

  • BehavioralWorkshop

    one-day (6 hour) program to help children and their parents or caregivers learn how to better manage chronic pain

  • BehavioralEducation

    The parent program includes psychoeducation regarding pain in the context of adolescent development, didactic and vignette-based practice of an adaptive parent communication response style (i.e., reflective listening), and concrete tools for setting up behavior plans to scaffold an adolescent's return to function for school, sleep, daily activities, and exercise. All parents are provided with a take-home workbook inclusive of neuroscience and psychoeducational materials as well as a list of resources to further solidify the information they learned.

06

What researchers measure

Primary outcomes

  1. Assess the efficacy of this program in change of pain interference: PROMIS

    Pediatric pain interference over the past 7 days on scale of 1 - 5. 1=Never, 2=Almost Never, 3=Sometimes, 4=Often, 5=Almost Always

    Time frame: up to 3 months after workshop

  2. Assess the efficacy of this program in change of pain interference: Pain Self Efficacy Scal - Adolescent

    Questionnaire to assess confidence with doing daily tasks when in pain. Scale of 1-5. 1=very sure, 2=pretty sure, 3=in the middle, 4=pretty unsure, 5=very unsure

    Time frame: up to 3 months after workshop

  3. Assess the efficacy of this program in change of pain interference: Functional Disability Inventory

    Questionnaire relating to difficulty of doing regular activities. Scale of 0 - 4. 0=no trouble, 1=a little trouble, 2=some trouble, 3=a lot of trouble, 4=impossible

    Time frame: up to 3 months after workshop

  4. Assess the efficacy of this program in change of pain interference: Post-Workshop Questionnaire for Parent/Caregiver

    Use of questionnaire to measure child's opinion of eductional material during workshop. Scale of 1 -5. 1=Strongly disagree, 2=disagree, 3=unsure, 4=Agree, 5=Strongly Agree

    Time frame: up to 3 months after workshop

  5. Assess the efficacy of this program in change of pain interference: Pain Catastrophizing Scale

    Assess thoughts and feelings when participant is in pain. Scale 0-4. 0=Not at all, 1=to a slight degree, 2=to a moderate degree, 3=to a great degree, 4=all the time

    Time frame: up to 3 months after workshop

  6. Assess the efficacy of this program in change of pain interference: Pediatric Pain Screen Tool

    Assess child's pain location and interference in daily life. Yes/No answers

    Time frame: up to 3 months after workshop

  7. Assess the efficacy of this program in change of pain interference: Treatment History Questionnaire

    Questionnaire to capture demographics, medical history, goals of treatment

    Time frame: up to 2 weeks before workshop

  8. Assess the efficacy of this program in change of pain interference: Adult Responses to Children's Symptoms

    Parent/Caregiver questionnaire to assess child's symptoms. Scale of 0 - 5, with 0=never and 5=often

    Time frame: up to 3 months after workshop

  9. Assess the efficacy of this program in change of pain interference: Pain Self Efficacy Scale - Child

    Questionnaire to assess confidence with doing daily tasks when in pain. Scale of 1-5. 1=very sure, 2=pretty sure, 3=in the middle, 4=pretty unsure, 5=very unsure

    Time frame: up to 3 months after workshop

  10. Determine if the workshop increases children's pain self-efficacy and improves patients function at our institution: PROMIS

    Pediatric pain interference over the past 7 days on scale of 1 - 5. 1=Never, 2=Almost Never, 3=Sometimes, 4=Often, 5=Almost Always

    Time frame: Up to 3 months following workshop

  11. Determine if the workshop increases children's pain self-efficacy and improves patients function at our institution: Post-Workshop Questionnaire for Parent/Caregiver

    Use of questionnaire to measure parent/caregiver's opinion of eductional material during workshop. Scale of 1 -5. 1=Strongly disagree, 2=disagree, 3=unsure, 4=Agree, 5=Strongly Agree

    Time frame: up to 3 months after workshop

  12. Determine if the workshop increases children's pain self-efficacy and improves patients function at our institution: Functional Disability

    Questionnaire relating to difficulty of doing regular activities. Scale of 0 - 4. 0=no trouble, 1=a little trouble, 2=some trouble, 3=a lot of trouble, 4=impossible

    Time frame: Up to 3 months following workshop

  13. Determine if the workshop increases parental management strategies of their child's pain at our institution: PROMIS

    Pediatric pain interference over the past 7 days on scale of 1 - 5. 1=Never, 2=Almost Never, 3=Sometimes, 4=Often, 5=Almost Always

    Time frame: Up to 3 months following workshop

  14. Determine if the workshop increases parental management strategies of their child's pain at our institution: Pain Evaluation Questionnaire

    Use of questionnaires to measure parental management strategies.

    Time frame: Up to 3 months following workshop

  15. Determine if the workshop increases parental management strategies of their child's pain at our institution: Functional Disability

    Questionnaire relating to difficulty of doing regular activities. Scale of 0 - 4. 0=no trouble, 1=a little trouble, 2=some trouble, 3=a lot of trouble, 4=impossible

    Time frame: Up to 3 months following workshop

07

Study locations

1 site
  • Washington University School of Medicine/Barnes Jewish Hospital
    St Louis, Missouri 63110, United States
08

References and documents

Publications

  • Coakley R, Wihak T, Kossowsky J, Iversen C, Donado C. The Comfort Ability Pain Management Workshop: A Preliminary, Nonrandomized Investigation of a Brief, Cognitive, Biobehavioral, and Parent Training Intervention for Pediatric Chronic Pain. J Pediatr Psychol. 2018 Apr 1;43(3):252-265. doi: 10.1093/jpepsy/jsx112. PubMed 29048506 ↗
  • Perquin CW, Hazebroek-Kampschreur AA, Hunfeld JA, van Suijlekom-Smit LW, Passchier J, van der Wouden JC. Chronic pain among children and adolescents: physician consultation and medication use. Clin J Pain. 2000 Sep;16(3):229-35. doi: 10.1097/00002508-200009000-00008. PubMed 11014396 ↗
  • Roth-Isigkeit A, Thyen U, Raspe HH, Stoven H, Schmucker P. Reports of pain among German children and adolescents: an epidemiological study. Acta Paediatr. 2004 Feb;93(2):258-63. PubMed 15046285 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2021 to primary completion in Dec 2023, 28 months.

Of 325 non-industry observational studies under Chronic Pain, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 54. This study's 28 months is above that.

Counting every sponsor, half of 350 studies reached it within 25 months; a quarter within 12 and three quarters within 51.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 17, 2019
First posted
Sep 9, 2019
StartActual
Aug 14, 2021
Primary completionActual
Dec 18, 2023
CompletionActual
Dec 18, 2023
Last update
May 1, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 1, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04081454
Responsible party
Sponsor
First posted
Sep 9, 2019
Start date
Aug 14, 2021
Primary completion
Dec 18, 2023
Completion
Dec 18, 2023
Last update
May 1, 2024

Study contacts

Jacob AuBuchon, MD
principal investigator · Washington University School of Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion